{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:18:12Z","timestamp":1792750692864,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["IndividuHeart"],"award-info":[{"award-number":["IndividuHeart"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"DZHK","doi-asserted-by":"crossref","award":["Main project"],"award-info":[{"award-number":["Main project"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010447","name":"DZHK","doi-asserted-by":"crossref","award":["Main project"],"award-info":[{"award-number":["Main project"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00424-018-2214-0","type":"journal-article","created":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T23:33:46Z","timestamp":1539560026000},"page":"755-768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes\u2014a systematic review"],"prefix":"10.1007","volume":"471","author":[{"given":"Thomas","family":"Eschenhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-5820","authenticated-orcid":false,"given":"Lucie","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"2214_CR1","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.celrep.2015.04.006","volume":"11","author":"T Aksel","year":"2015","unstructured":"Aksel T, Choe Yu E, Sutton S, Ruppel KM, Spudich JA (2015) Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector. Cell Rep 11:910\u2013920","journal-title":"Cell Rep"},{"key":"2214_CR2","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/gim.2014.205","volume":"17","author":"AA Alfares","year":"2015","unstructured":"Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL (2015) Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med 17:880\u2013888","journal-title":"Genet Med"},{"key":"2214_CR3","first-page":"3893","volume":"118","author":"F Baudenbacher","year":"2008","unstructured":"Baudenbacher F, Schober T, Pinto JR, Sidorov VY, Hilliard F, Solaro RJ, Potter JD, Knollmann BC (2008) Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest 118:3893\u20133903","journal-title":"J Clin Invest"},{"key":"2214_CR4","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1038\/emboj.2013.240","volume":"32","author":"M Bellin","year":"2013","unstructured":"Bellin M, Casini S, Davis RP, D\u2019Aniello C, Haas J, Ward-van Oostwaard D, Tertoolen LG, Jung CB, Elliott DA, Welling A, Laugwitz KL, Moretti A, Mummery CL (2013) Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J 32:3161\u20133175","journal-title":"EMBO J"},{"key":"2214_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.hrthm.2017.09.024","volume":"15","author":"R Ben Jehuda","year":"2018","unstructured":"Ben Jehuda R, Eisen B, Shemer Y, Mekies LN, Szantai A, Reiter I, Cui H, Guan K, Haron-Khun S, Freimark D, Sperling SR, Gherghiceanu M, Arad M, Binah O (2018) CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities. Heart Rhythm 15:267\u2013276","journal-title":"Heart Rhythm"},{"key":"2214_CR6","doi-asserted-by":"publisher","first-page":"23756","DOI":"10.1038\/srep23756","volume":"6","author":"JG Bensley","year":"2016","unstructured":"Bensley JG, De Matteo R, Harding R, Black MJ (2016) Three-dimensional direct measurement of cardiomyocyte volume, nuclearity, and ploidy in thick histological sections. Sci Rep 6:23756","journal-title":"Sci Rep"},{"key":"2214_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.celrep.2015.09.025","volume":"13","author":"MJ Birket","year":"2015","unstructured":"Birket MJ, Ribeiro MC, Kosmidis G, Ward D, Leitoguinho AR, van de Pol V, Dambrot C, Devalla HD, Davis RP, Mastroberardino PG, Atsma DE, Passier R, Mummery CL (2015) Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function. Cell Rep 13:733\u2013745","journal-title":"Cell Rep"},{"key":"2214_CR8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1242\/dmm.030320","volume":"10","author":"KO Brandao","year":"2017","unstructured":"Brandao KO, Tabel VA, Atsma DE, Mummery CL, Davis RP (2017) Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies. Dis Model Mech 10:1039\u20131059","journal-title":"Dis Model Mech"},{"key":"2214_CR9","doi-asserted-by":"publisher","first-page":"H107","DOI":"10.1152\/ajpheart.00162.2016","volume":"311","author":"KM Broughton","year":"2016","unstructured":"Broughton KM, Li J, Sarmah E, Warren CM, Lin YH, Henze MP, Sanchez-Freire V, Solaro RJ, Russell B (2016) A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation. Am J Physiol Heart Circ Physiol 311:H107\u2013H117","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2214_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cardiores.2004.04.009","volume":"63","author":"L Carrier","year":"2004","unstructured":"Carrier L, Knoell R, Vignier N, Keller DI, Bausero P, Prudhon B, Isnard R, Ambroisine ML, Fiszman M, Ross J Jr, Schwartz K, Chien KR (2004) Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res 63:293\u2013304","journal-title":"Cardiovasc Res"},{"key":"2214_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature09005","volume":"465","author":"X Carvajal-Vergara","year":"2010","unstructured":"Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, Yang L, Kaplan AD, Adler ED, Rozov R, Ge Y, Cohen N, Edelmann LJ, Chang B, Waghray A, Su J, Pardo S, Lichtenbelt KD, Tartaglia M, Gelb BD, Lemischka IR (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465:808\u2013812","journal-title":"Nature"},{"key":"2214_CR12","doi-asserted-by":"publisher","first-page":"e0146697","DOI":"10.1371\/journal.pone.0146697","volume":"11","author":"TJ Cashman","year":"2016","unstructured":"Cashman TJ, Josowitz R, Johnson BV, Gelb BD, Costa KD (2016) Human engineered cardiac tissues created using induced pluripotent stem cells reveal functional characteristics of BRAF-mediated hypertrophic cardiomyopathy. PLoS One 11:e0146697","journal-title":"PLoS One"},{"key":"2214_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cardiores.2005.11.009","volume":"69","author":"O Cazorla","year":"2006","unstructured":"Cazorla O, Szilagyi S, Vignier N, Salazar G, Kramer E, Vassort G, Carrier L, Lacampagne A (2006) Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res 69:370\u2013380","journal-title":"Cardiovasc Res"},{"key":"2214_CR14","doi-asserted-by":"publisher","first-page":"H2112","DOI":"10.1152\/ajpheart.00571.2005","volume":"289","author":"M Chandra","year":"2005","unstructured":"Chandra M, Tschirgi ML, Tardiff JC (2005) Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation. Am J Physiol Heart Circ Physiol 289:H2112\u2013H2119","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2214_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijcard.2017.01.009","volume":"232","author":"SJ Chou","year":"2017","unstructured":"Chou SJ, Yu WC, Chang YL, Chen WY, Chang WC, Chien Y, Yen JC, Liu YY, Chen SJ, Wang CY, Chen YH, Niu DM, Lin SJ, Chen JW, Chiou SH, Leu HB (2017) Energy utilization of induced pluripotent stem cell-derived cardiomyocyte in Fabry disease. Int J Cardiol 232:255\u2013263","journal-title":"Int J Cardiol"},{"key":"2214_CR16","doi-asserted-by":"publisher","unstructured":"Cirino AL, Lakdawala NK, McDonough B, Conner L, Adler D, Weinfeld M, O\u2019Gara P, Rehm HL, Machini K, Lebo M, Blout C, Green RC, MacRae CA, Seidman CE, Ho CY, MedSeq P (2017) A comparison of whole genome sequencing to multigene panel testing in hypertrophic cardiomyopathy patients. Circ Cardiovasc Genet 10(5):e001768. https:\/\/doi.org\/10.1161\/CIRCGENETICS.117.001768","DOI":"10.1161\/CIRCGENETICS.117.001768"},{"key":"2214_CR17","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","volume":"41","author":"JG Crilley","year":"2003","unstructured":"Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, McKenna WJ, Ostman-Smith I, Clarke K, Watkins H (2003) Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41:1776\u20131782","journal-title":"J Am Coll Cardiol"},{"key":"2214_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/jcmm.12356","volume":"18","author":"C Dambrot","year":"2014","unstructured":"Dambrot C, Braam SR, Tertoolen LG, Birket M, Atsma DE, Mummery CL (2014) Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes. J Cell Mol Med 18:1509\u20131518","journal-title":"J Cell Mol Med"},{"key":"2214_CR19","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","volume":"165","author":"J Davis","year":"2016","unstructured":"Davis J, Davis LC, Correll RN, Makarewich CA, Schwanekamp JA, Moussavi-Harami F, Wang D, York AJ, Wu H, Houser SR, Seidman CE, Seidman JG, Regnier M, Metzger JM, Wu JC, Molkentin JD (2016) A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy. Cell 165:1147\u20131159","journal-title":"Cell"},{"key":"2214_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/CIRCRESAHA.106.146670","volume":"101","author":"CK Du","year":"2007","unstructured":"Du CK, Morimoto S, Nishii K, Minakami R, Ohta M, Tadano N, Lu QW, Wang YY, Zhan DY, Mochizuki M, Kita S, Miwa Y, Takahashi-Yanaga F, Iwamoto T, Ohtsuki I, Sasaguri T (2007) Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 101:185\u2013194","journal-title":"Circ Res"},{"key":"2214_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/cvr\/cvv006","volume":"105","author":"DJ Duncker","year":"2015","unstructured":"Duncker DJ, Bakkers J, Brundel BJ, Robbins J, Tardiff JC, Carrier L (2015) Animal and in silico models for the study of sarcomeric cardiomyopathies. Cardiovasc Res 105:439\u2013448","journal-title":"Cardiovasc Res"},{"key":"2214_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/cvr\/cvv017","volume":"105","author":"T Eschenhagen","year":"2015","unstructured":"Eschenhagen T, Mummery C, Knollmann BC (2015) Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes. Cardiovasc Res 105:424\u2013438","journal-title":"Cardiovasc Res"},{"key":"2214_CR23","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.yjmcc.2012.03.009","volume":"52","author":"B Fraysse","year":"2012","unstructured":"Fraysse B, Weinberger F, Bardswell SC, Cuello F, Vignier N, Geertz B, Starbatty J, Kramer E, Coirault C, Eschenhagen T, Kentish JC, Avkiran M, Carrier L (2012) Increased myofilament Ca(2+) sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol 52:1299\u20131307","journal-title":"J Mol Cell Cardiol"},{"key":"2214_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ppedcard.2010.11.006","volume":"31","author":"AH Frazier","year":"2011","unstructured":"Frazier AH, Ramirez-Correa GA, Murphy AM (2011) Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy. Prog Pediatr Cardiol 31:29\u201333","journal-title":"Prog Pediatr Cardiol"},{"key":"2214_CR25","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.2174\/1389201011208062467","volume":"13","author":"FW Friedrich","year":"2012","unstructured":"Friedrich FW, Carrier L (2012) Genetics of hypertrophic and dilated cardiomyopathy. Curr Pharm Biotechnol 13:2467\u20132476","journal-title":"Curr Pharm Biotechnol"},{"key":"2214_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.hfc.2017.12.004","volume":"14","author":"AC Garfinkel","year":"2018","unstructured":"Garfinkel AC, Seidman JG, Seidman CE (2018) Genetic pathogenesis of hypertrophic and dilated cardiomyopathy. Heart Fail Clin 14:139\u2013146","journal-title":"Heart Fail Clin"},{"key":"2214_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/emmm.201202168","volume":"5","author":"C Gedicke-Hornung","year":"2013","unstructured":"Gedicke-Hornung C, Behrens-Gawlik V, Reischmann S, Geertz B, Stimpel D, Weinberger F, Schlossarek S, Precigout G, Braren I, Eschenhagen T, Mearini G, Lorain S, Voit T, Dreyfus PA, Garcia L, Carrier L (2013) Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice. EMBO Mol Med 5:1128\u20131145","journal-title":"EMBO Mol Med"},{"key":"2214_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.272.5262.731","volume":"272","author":"AA Geisterfer-Lowrance","year":"1996","unstructured":"Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG (1996) A mouse model of familial hypertrophic cardiomyopathy. Science 272:731\u2013734","journal-title":"Science"},{"key":"2214_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.15252\/emmm.201505047","volume":"7","author":"M Gramlich","year":"2015","unstructured":"Gramlich M, Pane LS, Zhou Q, Chen Z, Murgia M, Schotterl S, Goedel A, Metzger K, Brade T, Parrotta E, Schaller M, Gerull B, Thierfelder L, Aartsma-Rus A, Labeit S, Atherton JJ, McGaughran J, Harvey RP, Sinnecker D, Mann M, Laugwitz KL, Gawaz MP, Moretti A (2015) Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy. EMBO Mol Med 7:562\u2013576","journal-title":"EMBO Mol Med"},{"key":"2214_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.aad3456","volume":"351","author":"EM Green","year":"2016","unstructured":"Green EM, Wakimoto H, Anderson RL, Evanchik MJ, Gorham JM, Harrison BC, Henze M, Kawas R, Oslob JD, Rodriguez HM, Song Y, Wan W, Leinwand LA, Spudich JA, McDowell RS, Seidman JG, Seidman CE (2016) A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351:617\u2013621","journal-title":"Science"},{"key":"2214_CR31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/jcmm.13392","volume":"22","author":"T Hallas","year":"2018","unstructured":"Hallas T, Eisen B, Shemer Y, Ben Jehuda R, Mekies LN, Naor S, Schick R, Eliyahu S, Reiter I, Vlodavsky E, Katz YS, Ounap K, Lorber A, Rodenburg R, Mandel H, Gherghiceanu M, Binah O (2018) Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes. J Cell Mol Med 22:913\u2013925","journal-title":"J Cell Mol Med"},{"key":"2214_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cvr\/cvu205","volume":"104","author":"L Han","year":"2014","unstructured":"Han L, Li Y, Tchao J, Kaplan AD, Lin B, Li Y, Mich-Basso J, Lis A, Hassan N, London B, Bett GC, Tobita K, Rasmusson RL, Yang L (2014) Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc Res 104:258\u2013269","journal-title":"Cardiovasc Res"},{"key":"2214_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.RES.0000012222.70819.64","volume":"90","author":"SP Harris","year":"2002","unstructured":"Harris SP, Bartley CR, Hacker TA, McDonald KS, Douglas PS, Greaser ML, Powers PA, Moss RL (2002) Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 90:594\u2013601","journal-title":"Circ Res"},{"key":"2214_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yjmcc.2017.05.007","volume":"108","author":"SI Hashem","year":"2017","unstructured":"Hashem SI, Murphy AN, Divakaruni AS, Klos ML, Nelson BC, Gault EC, Rowland TJ, Perry CN, Gu Y, Dalton ND, Bradford WH, Devaney EJ, Peterson KL, Jones KL, MRG T, Chen J, Chi NC, Adler ED (2017) Impaired mitophagy facilitates mitochondrial damage in Danon disease. J Mol Cell Cardiol 108:86\u201394","journal-title":"J Mol Cell Cardiol"},{"key":"2214_CR35","doi-asserted-by":"crossref","unstructured":"Hinson JT, Chopra A, Nafissi N, Polacheck WJ, Benson CC, Swist S, Gorham J, Yang L, Schafer S, Sheng CC, Haghighi A, Homsy J, Hubner N, Church G, Cook SA, Linke WA, Chen CS, Seidman JG, Seidman CE (2015) HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349:982\u2013986","DOI":"10.1126\/science.aaa5458"},{"key":"2214_CR36","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1161\/01.CIR.0000019070.70491.6D","volume":"105","author":"CY Ho","year":"2002","unstructured":"Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD (2002) Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105:2992\u20132997","journal-title":"Circulation"},{"key":"2214_CR37","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCGENETICS.109.862128","volume":"2","author":"CY Ho","year":"2009","unstructured":"Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, Rivero J, Cirino AL, Andersen PS, Christiansen M, Maron BJ, Orav EJ, Kober L (2009) Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2:314\u2013321","journal-title":"Circ Cardiovasc Genet"},{"key":"2214_CR38","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.stemcr.2018.01.012","volume":"10","author":"A Horvath","year":"2018","unstructured":"Horvath A, Lemoine MD, Loser A, Mannhardt I, Flenner F, Uzun AU, Neuber C, Breckwoldt K, Hansen A, Girdauskas E, Reichenspurner H, Willems S, Jost N, Wettwer E, Eschenhagen T, Christ T (2018) Low resting membrane potential and low inward rectifier potassium currents are not inherent features of hiPSC-derived cardiomyocytes. Stem Cell Rep 10:822\u2013833","journal-title":"Stem Cell Rep"},{"key":"2214_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11745-016-4229-7","volume":"52","author":"N Ikon","year":"2017","unstructured":"Ikon N, Ryan RO (2017) Barth syndrome: connecting cardiolipin to cardiomyopathy. Lipids 52:99\u2013108","journal-title":"Lipids"},{"key":"2214_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature09747","volume":"471","author":"I Itzhaki","year":"2011","unstructured":"Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L (2011) Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471:225\u2013229","journal-title":"Nature"},{"key":"2214_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.stemcr.2016.07.018","volume":"7","author":"R Josowitz","year":"2016","unstructured":"Josowitz R, Mulero-Navarro S, Rodriguez NA, Falce C, Cohen N, Ullian EM, Weiss LA, Rauen KA, Sobie EA, Gelb BD (2016) Autonomous and non-autonomous defects underlie hypertrophic cardiomyopathy in BRAF-mutant hiPSC-derived cardiomyocytes. Stem Cell Rep 7:355\u2013369","journal-title":"Stem Cell Rep"},{"key":"2214_CR42","doi-asserted-by":"publisher","unstructured":"Judge LM, Perez-Bermejo JA, Truong A, Ribeiro AJ, Yoo JC, Jensen CL, Mandegar MA, Huebsch N, Kaake RM, So PL, Srivastava D, Pruitt BL, Krogan NJ, Conklin BR (2017) A BAG3 chaperone complex maintains cardiomyocyte function during proteotoxic stress. JCI Insight 2(14):94623. https:\/\/doi.org\/10.1172\/jci.insight.94623","DOI":"10.1172\/jci.insight.94623"},{"key":"2214_CR43","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1038\/ncomms7955","volume":"6","author":"I Karakikes","year":"2015","unstructured":"Karakikes I, Stillitano F, Nonnenmacher M, Tzimas C, Sanoudou D, Termglinchan V, Kong CW, Rushing S, Hansen J, Ceholski D, Kolokathis F, Kremastinos D, Katoulis A, Ren L, Cohen N, Gho JM, Tsiapras D, Vink A, Wu JC, Asselbergs FW, Li RA, Hulot JS, Kranias EG, Hajjar RJ (2015) Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy. Nat Commun 6:6955","journal-title":"Nat Commun"},{"key":"2214_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1601959","volume":"3","author":"M Kawana","year":"2017","unstructured":"Kawana M, Sarkar SS, Sutton S, Ruppel KM, Spudich JA (2017) Biophysical properties of human beta-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy. Sci Adv 3:e1601959","journal-title":"Sci Adv"},{"key":"2214_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.yjmcc.2003.12.006","volume":"36","author":"DI Keller","year":"2004","unstructured":"Keller DI, Coirault C, Rau T, Cheav T, Weyand M, Amann K, Lecarpentier Y, Richard P, Eschenhagen T, Carrier L (2004) Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties. J Mol Cell Cardiol 36:355\u2013362","journal-title":"J Mol Cell Cardiol"},{"key":"2214_CR46","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature22403","volume":"546","author":"H Kilpinen","year":"2017","unstructured":"Kilpinen H, Goncalves A, Leha A, Afzal V, Alasoo K, Ashford S, Bala S, Bensaddek D, Casale FP, Culley OJ, Danecek P, Faulconbridge A, Harrison PW, Kathuria A, McCarthy D, McCarthy SA, Meleckyte R, Memari Y, Moens N, Soares F, Mann A, Streeter I, Agu CA, Alderton A, Nelson R, Harper S, Patel M, White A, Patel SR, Clarke L, Halai R, Kirton CM, Kolb-Kokocinski A, Beales P, Birney E, Danovi D, Lamond AI, Ouwehand WH, Vallier L, Watt FM, Durbin R, Stegle O, Gaffney DJ (2017) Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546:370\u2013375","journal-title":"Nature"},{"key":"2214_CR47","doi-asserted-by":"publisher","first-page":"H1242","DOI":"10.1152\/ajpheart.00686.2004","volume":"288","author":"SE Kirschner","year":"2005","unstructured":"Kirschner SE, Becker E, Antognozzi M, Kubis HP, Francino A, Navarro-Lopez F, Bit-Avragim N, Perrot A, Mirrakhimov MM, Osterziel KJ, McKenna WJ, Brenner B, Kraft T (2005) Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells. Am J Physiol Heart Circ Physiol 288:H1242\u2013H1251","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2214_CR48","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/01.RES.0000096363.85588.9A","volume":"93","author":"FS Korte","year":"2003","unstructured":"Korte FS, McDonald KS, Harris SP, Moss RL (2003) Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C. Circ Res 93:752\u2013758","journal-title":"Circ Res"},{"key":"2214_CR49","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/CIRCRESAHA.116.309804","volume":"119","author":"T Kraft","year":"2016","unstructured":"Kraft T, Montag J, Radocaj A, Brenner B (2016) Hypertrophic cardiomyopathy: cell-to-cell imbalance in gene expression and contraction force as trigger for disease phenotype development. Circ Res 119:992\u2013995","journal-title":"Circ Res"},{"key":"2214_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","volume":"12","author":"F Lan","year":"2013","unstructured":"Lan F, Lee AS, Liang P, Sanchez-Freire V, Nguyen PK, Wang L, Han L, Yen M, Wang Y, Sun N, Abilez OJ, Hu S, Ebert AD, Navarrete EG, Simmons CS, Wheeler M, Pruitt B, Lewis R, Yamaguchi Y, Ashley EA, Bers DM, Robbins RC, Longaker MT, Wu JC (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12:101\u2013113","journal-title":"Cell Stem Cell"},{"key":"2214_CR51","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.ijcard.2015.11.101","volume":"203","author":"YK Lee","year":"2016","unstructured":"Lee YK, Lau YM, Ng KM, Lai WH, Ho SL, Tse HF, Siu CW, Ho PW (2016) Efficient attenuation of Friedreich\u2019s ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. Int J Cardiol 203:964\u2013971","journal-title":"Int J Cardiol"},{"key":"2214_CR52","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.stemcr.2018.01.013","volume":"10","author":"S Li","year":"2018","unstructured":"Li S, Pan H, Tan C, Sun Y, Song Y, Zhang X, Yang W, Wang X, Li D, Dai Y, Ma Q, Xu C, Zhu X, Kang L, Fu Y, Xu X, Shu J, Zhou N, Han F, Qin D, Huang W, Liu Z, Yan Q (2018) Mitochondrial dysfunctions contribute to hypertrophic cardiomyopathy in patient iPSC-derived cardiomyocytes with MT-RNR2 mutation. Stem Cell Rep 10:808\u2013821","journal-title":"Stem Cell Rep"},{"key":"2214_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stem.2013.07.001","volume":"13","author":"G Liang","year":"2013","unstructured":"Liang G, Zhang Y (2013) Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13:149\u2013159","journal-title":"Cell Stem Cell"},{"key":"2214_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1242\/dmm.019505","volume":"8","author":"B Lin","year":"2015","unstructured":"Lin B, Li Y, Han L, Kaplan AD, Ao Y, Kalra S, Bett GC, Rasmusson RL, Denning C, Yang L (2015) Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy. Dis Model Mech 8:457\u2013466","journal-title":"Dis Model Mech"},{"key":"2214_CR55","doi-asserted-by":"publisher","first-page":"eaap9004","DOI":"10.1126\/sciadv.aap9004","volume":"4","author":"C Long","year":"2018","unstructured":"Long C, Li H, Tiburcy M, Rodriguez-Caycedo C, Kyrychenko V, Zhou H, Zhang Y, Min YL, Shelton JM, Mammen PPA, Liaw NY, Zimmermann WH, Bassel-Duby R, Schneider JW, Olson EN (2018) Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing. Sci Adv 4:eaap9004","journal-title":"Sci Adv"},{"key":"2214_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.yjmcc.2017.06.001","volume":"108","author":"ML Lynn","year":"2017","unstructured":"Lynn ML, Tal Grinspan L, Holeman TA, Jimenez J, Strom J, Tardiff JC (2017) The structural basis of alpha-tropomyosin linked (Asp230Asn) familial dilated cardiomyopathy. J Mol Cell Cardiol 108:127\u2013137","journal-title":"J Mol Cell Cardiol"},{"key":"2214_CR57","doi-asserted-by":"crossref","unstructured":"Ma N, Zhang J, Itzhaki I, Zhang SL, Chen H, Haddad F, Kitani T, Wilson KD, Tian L, Shrestha R, Wu H, Lam CK, Sayed N, Wu JC (2018) Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells. Circulation:CIRCULATIONAHA.117.032273","DOI":"10.1161\/CIRCULATIONAHA.117.032273"},{"key":"2214_CR58","doi-asserted-by":"publisher","first-page":"10846","DOI":"10.1038\/s41598-018-29263-3","volume":"8","author":"TSH Mak","year":"2018","unstructured":"Mak TSH, Lee YK, Tang CS, Hai JSH, Ran X, Sham PC, Tse HF (2018) Coverage and diagnostic yield of whole exome sequencing for the evaluation of cases with dilated and hypertrophic cardiomyopathy. Sci Rep 8:10846","journal-title":"Sci Rep"},{"key":"2214_CR59","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian AJ, Braunwald E (2017) Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121:749\u2013770","journal-title":"Circ Res"},{"key":"2214_CR60","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart A, Council on Clinical Cardiology HF, Transplantation C, Quality of C, Outcomes R, Functional G, Translational Biology Interdisciplinary Working G, Council on E, and Prevention (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807\u20131816","journal-title":"Circulation"},{"key":"2214_CR61","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1172\/JCI7377","volume":"104","author":"BK McConnell","year":"1999","unstructured":"McConnell BK, Jones KA, Fatkin D, Arroyo LH, Lee RT, Aristizabal O, Turnbull DH, Georgakopoulos D, Kass D, Bond M, Niimura H, Schoen FJ, Conner D, Fischman DA, Seidman CE, Seidman JG (1999) Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 104:1235\u20131244","journal-title":"J Clin Invest"},{"key":"2214_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/01.RES.88.4.383","volume":"88","author":"BK McConnell","year":"2001","unstructured":"McConnell BK, Fatkin D, Semsarian C, Jones KA, Georgakopoulos D, Maguire CT, Healey MJ, Mudd JO, Moskowitz IP, Conner DA, Giewat M, Wakimoto H, Berul CI, Schoen FJ, Kass DA, Seidman CE, Seidman JG (2001) Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res 88:383\u2013389","journal-title":"Circ Res"},{"key":"2214_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2016.03.009","volume":"94","author":"JW McNamara","year":"2016","unstructured":"McNamara JW, Li A, Smith NJ, Lal S, Graham RM, Kooiker KB, van Dijk SJ, Remedios CGD, Harris SP, Cooke R (2016) Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes. J Mol Cell Cardiol 94:65\u201371","journal-title":"J Mol Cell Cardiol"},{"key":"2214_CR64","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1038\/mtna.2013.31","volume":"2","author":"G Mearini","year":"2013","unstructured":"Mearini G, Stimpel D, Kramer E, Geertz B, Braren I, Gedicke-Hornung C, Precigout G, Muller OJ, Katus HA, Eschenhagen T, Voit T, Garcia L, Lorain S, Carrier L (2013) Repair of Mybpc3 mRNA by 5\u2032-trans-splicing in a mouse model of hypertrophic cardiomyopathy. Mol Ther Nucleic Acids 2:e102","journal-title":"Mol Ther Nucleic Acids"},{"key":"2214_CR65","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1038\/ncomms6515","volume":"5","author":"G Mearini","year":"2014","unstructured":"Mearini G, Stimpel D, Geertz B, Weinberger F, Kr\u00e4mer E, Schlossarek S, Mourot-Filiatre J, St\u00f6hr A, Dutshc A, Wijnker PJM, Braren I, Katus HA, M\u00fcller OJ, Voit T, Eschenhagen T, Carrier L (2014) Mybpc3 gene therapy for neonatal cardiomyopathy enables longterm disease prevention in mice. Nat Commun 5:5515","journal-title":"Nat Commun"},{"key":"2214_CR66","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcmg.2008.08.003","volume":"2","author":"M Michels","year":"2009","unstructured":"Michels M, Soliman OI, Kofflard MJ, Hoedemaekers YM, Dooijes D, Majoor-Krakauer D, ten Cate FJ (2009) Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging 2:58\u201364","journal-title":"JACC Cardiovasc Imaging"},{"key":"2214_CR67","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1469-7793.2001.0583c.xd","volume":"536","author":"DE Montgomery","year":"2001","unstructured":"Montgomery DE, Tardiff JC, Chandra M (2001) Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice. J Physiol 536:583\u2013592","journal-title":"J Physiol"},{"key":"2214_CR68","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","volume":"363","author":"A Moretti","year":"2010","unstructured":"Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Hohnke C, Hofmann F, Seyfarth M, Sinnecker D, Schomig A, Laugwitz KL (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363:1397\u20131409","journal-title":"N Engl J Med"},{"key":"2214_CR69","doi-asserted-by":"crossref","unstructured":"Mosqueira D, Mannhardt I, Bhagwan JR, Lis-Slimak K, Katili P, Scott E, Hassan M, Prondzynski M, Harmer SC, Tinker A, Smith JGW, Carrier L, Williams PM, Gaffney D, Eschenhagen T, Hansen A, Denning C (2018) CRISPR\/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. Eur Heart J","DOI":"10.1093\/eurheartj\/ehy249"},{"key":"2214_CR70","first-page":"e000043","volume":"11","author":"K Musunuru","year":"2018","unstructured":"Musunuru K, Sheikh F, Gupta RM, Houser SR, Maher KO, Milan DJ, Terzic A, Wu JC, American Heart Association Council on Functional G, Translational B, Council on Cardiovascular Disease in the Y, Council on C, and Stroke N (2018) Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine: a scientific statement from the American Heart Association. Circ Genom Precis Med 11:e000043","journal-title":"Circ Genom Precis Med"},{"key":"2214_CR71","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/01.CIR.86.6.1810","volume":"86","author":"S Neubauer","year":"1992","unstructured":"Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Mader H, Kromer EP, Riegger GA, Lackner K et al (1992) 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86:1810\u20131818","journal-title":"Circulation"},{"key":"2214_CR72","doi-asserted-by":"publisher","first-page":"1684792","DOI":"10.1155\/2016\/1684792","volume":"2016","author":"M Ojala","year":"2016","unstructured":"Ojala M, Prajapati C, Polonen RP, Rajala K, Pekkanen-Mattila M, Rasku J, Larsson K, Aalto-Setala K (2016) Mutation-specific phenotypes in hiPSC-derived cardiomyocytes carrying either myosin-binding protein C or alpha-tropomyosin mutation for hypertrophic cardiomyopathy. Stem Cells Int 2016:1684792","journal-title":"Stem Cells Int"},{"key":"2214_CR73","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/eurheartj\/ehw160","volume":"37","author":"DG Phelan","year":"2016","unstructured":"Phelan DG, Anderson DJ, Howden SE, Wong RC, Hickey PF, Pope K, Wilson GR, Pebay A, Davis AM, Petrou S, Elefanty AG, Stanley EG, James PA, Macciocca I, Bahlo M, Cheung MM, Amor DJ, Elliott DA, Lockhart PJ (2016) ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy. Eur Heart J 37:2586\u20132590","journal-title":"Eur Heart J"},{"key":"2214_CR74","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.stemcr.2016.04.006","volume":"6","author":"JM Pioner","year":"2016","unstructured":"Pioner JM, Racca AW, Klaiman JM, Yang KC, Guan X, Pabon L, Muskheli V, Zaunbrecher R, Macadangdang J, Jeong MY, Mack DL, Childers MK, Kim DH, Tesi C, Poggesi C, Murry CE, Regnier M (2016) Isolation and mechanical measurements of myofibrils from human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rep 6:885\u2013896","journal-title":"Stem Cell Rep"},{"key":"2214_CR75","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCRESAHA.107.158774","volume":"101","author":"L Pohlmann","year":"2007","unstructured":"Pohlmann L, Kroger I, Vignier N, Schlossarek S, Kramer E, Coirault C, Sultan KR, El-Armouche A, Winegrad S, Eschenhagen T, Carrier L (2007) Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res 101:928\u2013938","journal-title":"Circ Res"},{"key":"2214_CR76","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.omtn.2017.05.008","volume":"7","author":"M Prondzynski","year":"2017","unstructured":"Prondzynski M, Kramer E, Laufer SD, Shibamiya A, Pless O, Flenner F, Muller OJ, Munch J, Redwood C, Hansen A, Patten M, Eschenhagen T, Mearini G, Carrier L (2017) Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-derived cardiomyocytes. Mol Ther Nucleic Acids 7:475\u2013486","journal-title":"Mol Ther Nucleic Acids"},{"key":"2214_CR77","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1074\/jbc.M114.628628","volume":"290","author":"KK Raval","year":"2015","unstructured":"Raval KK, Tao R, White BE, De Lange WJ, Koonce CH, Yu J, Kishnani PS, Thomson JA, Mosher DF, Ralphe JC, Kamp TJ (2015) Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes. J Biol Chem 290:3121\u20133136","journal-title":"J Biol Chem"},{"key":"2214_CR78","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","volume":"107","author":"P Richard","year":"2003","unstructured":"Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations and implications for molecular diagnosis strategy. Circulation 107:2227\u20132232","journal-title":"Circulation"},{"key":"2214_CR79","doi-asserted-by":"publisher","first-page":"40710","DOI":"10.1074\/jbc.M203446200","volume":"277","author":"P Robinson","year":"2002","unstructured":"Robinson P, Mirza M, Knott A, Abdulrazzak H, Willott R, Marston S, Watkins H, Redwood C (2002) Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 277:40710\u201340716","journal-title":"J Biol Chem"},{"key":"2214_CR80","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.scr.2017.02.015","volume":"20","author":"SB Ross","year":"2017","unstructured":"Ross SB, Fraser ST, Nowak N, Semsarian C (2017) Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene. Stem Cell Res 20:88\u201390","journal-title":"Stem Cell Res"},{"key":"2214_CR81","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1161\/CIRCULATIONAHA.118.034857","volume":"137","author":"EJ Rowin","year":"2018","unstructured":"Rowin EJ, Maron MS, Maron BJ (2018) Response by Rowin et al to letter regarding article, \u201cClinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy\u201d. Circulation 137:2541\u20132542","journal-title":"Circulation"},{"key":"2214_CR82","doi-asserted-by":"publisher","first-page":"15023","DOI":"10.1038\/mtm.2015.23","volume":"2","author":"Y Sato","year":"2015","unstructured":"Sato Y, Kobayashi H, Higuchi T, Shimada Y, Era T, Kimura S, Eto Y, Ida H, Ohashi T (2015) Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient. Mol Ther Methods Clin Dev 2:15023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2214_CR83","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/S0006-3495(96)79711-4","volume":"70","author":"H Satoh","year":"1996","unstructured":"Satoh H, Delbridge LM, Blatter LA, Bers DM (1996) Surface:volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: species-dependence and developmental effects. Biophys J 70:1494\u20131504","journal-title":"Biophys J"},{"key":"2214_CR84","doi-asserted-by":"publisher","first-page":"803","DOI":"10.18632\/aging.100503","volume":"4","author":"CW Siu","year":"2012","unstructured":"Siu CW, Lee YK, Ho JC, Lai WH, Chan YC, Ng KM, Wong LY, Au KW, Lau YM, Zhang J, Lay KW, Colman A, Tse HF (2012) Modeling of lamin A\/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells. Aging (Albany NY) 4:803\u2013822","journal-title":"Aging (Albany NY)"},{"key":"2214_CR85","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yjmcc.2018.03.012","volume":"118","author":"P Spitalieri","year":"2018","unstructured":"Spitalieri P, Talarico RV, Caioli S, Murdocca M, Serafino A, Girasole M, Dinarelli S, Longo G, Pucci S, Botta A, Novelli G, Zona C, Mango R, Sangiuolo F (2018) Modelling the pathogenesis of myotonic dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes. J Mol Cell Cardiol 118:95\u2013109","journal-title":"J Mol Cell Cardiol"},{"key":"2214_CR86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.yjmcc.2017.09.008","volume":"113","author":"K Streckfuss-Bomeke","year":"2017","unstructured":"Streckfuss-Bomeke K, Tiburcy M, Fomin A, Luo X, Li W, Fischer C, Ozcelik C, Perrot A, Sossalla S, Haas J, Vidal RO, Rebs S, Khadjeh S, Meder B, Bonn S, Linke WA, Zimmermann WH, Hasenfuss G, Guan K (2017) Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol 113:9\u201321","journal-title":"J Mol Cell Cardiol"},{"key":"2214_CR87","doi-asserted-by":"publisher","first-page":"130ra147","DOI":"10.1126\/scitranslmed.3003552","volume":"4","author":"N Sun","year":"2012","unstructured":"Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, Abilez OJ, Navarrete EG, Hu S, Wang L, Lee A, Pavlovic A, Lin S, Chen R, Hajjar RJ, Snyder MP, Dolmetsch RE, Butte MJ, Ashley EA, Longaker MT, Robbins RC, Wu JC (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 4:130ra147","journal-title":"Sci Transl Med"},{"key":"2214_CR88","doi-asserted-by":"publisher","first-page":"14406","DOI":"10.1073\/pnas.95.24.14406","volume":"95","author":"HL Sweeney","year":"1998","unstructured":"Sweeney HL, Feng HS, Yang Z, Watkins H (1998) Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. Proc Natl Acad Sci U S A 95:14406\u201314410","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2214_CR89","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872","journal-title":"Cell"},{"key":"2214_CR90","doi-asserted-by":"publisher","unstructured":"Tanaka A, Yuasa S, Mearini G, Egashira T, Seki T, Kodaira M, Kusumoto D, Kuroda Y, Okata S, Suzuki T, Inohara T, Arimura T, Makino S, Kimura K, Kimura A, Furukawa T, Carrier L, Node K, Fukuda K (2014) Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J Am Heart Assoc 3(6):e001263. https:\/\/doi.org\/10.1161\/JAHA.114.001263","DOI":"10.1161\/JAHA.114.001263"},{"key":"2214_CR91","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/hmg\/dds556","volume":"22","author":"HF Tse","year":"2013","unstructured":"Tse HF, Ho JC, Choi SW, Lee YK, Butler AW, Ng KM, Siu CW, Simpson MA, Lai WH, Chan YC, Au KW, Zhang J, Lay KW, Esteban MA, Nicholls JM, Colman A, Sham PC (2013) Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum Mol Genet 22:1395\u20131403","journal-title":"Hum Mol Genet"},{"key":"2214_CR92","doi-asserted-by":"publisher","first-page":"9017","DOI":"10.1074\/jbc.RA118.001938","volume":"293","author":"Z Ujfalusi","year":"2018","unstructured":"Ujfalusi Z, Vera CD, Mijailovich SM, Svicevic M, Yu EC, Kawana M, Ruppel KM, Spudich JA, Geeves MA, Leinwand LA (2018) Dilated cardiomyopathy myosin mutants have reduced force-generating capacity. J Biol Chem 293:9017\u20139029","journal-title":"J Biol Chem"},{"key":"2214_CR93","doi-asserted-by":"publisher","first-page":"H1611","DOI":"10.1152\/ajpheart.00481.2015","volume":"310","author":"R Vaidyanathan","year":"2016","unstructured":"Vaidyanathan R, Markandeya YS, Kamp TJ, Makielski JC, January CT, Eckhardt LL (2016) IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes. Am J Physiol Heart Circ Physiol 310:H1611\u2013H1621","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2214_CR94","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/cvr\/cvv019","volume":"105","author":"J Velden van der","year":"2015","unstructured":"van der Velden J, Ho CY, Tardiff JC, Olivotto I, Knollmann BC, Carrier L (2015) Research priorities in sarcomeric cardiomyopathies. Cardiovasc Res 105:449\u2013456","journal-title":"Cardiovasc Res"},{"key":"2214_CR95","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","volume":"119","author":"SJ Dijk van","year":"2009","unstructured":"van Dijk SJ, Dooijes D, Dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, Ten Cate FJ, Stienen GJ, van der Velden J (2009) Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119:1473\u20131483","journal-title":"Circulation"},{"key":"2214_CR96","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/CIRCHEARTFAILURE.111.963702","volume":"5","author":"SJ Dijk van","year":"2012","unstructured":"van Dijk SJ, Paalberends ER, Najafi A, Michels M, Sadayappan S, Carrier L, Boontje NM, Kuster DW, van Slegtenhorst M, Dooijes D, Dos Remedios C, Ten Cate FJ, Stienen GJ, van der Velden J (2012) Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function. Circ Heart Fail 5:36\u201346","journal-title":"Circ Heart Fail"},{"issue":"Pt 3","key":"2214_CR97","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1469-7793.1998.653bv.x","volume":"506","author":"G Vandecasteele","year":"1998","unstructured":"Vandecasteele G, Eschenhagen T, Fischmeister R (1998) Role of the NO-cGMP pathway in the muscarinic regulation of the L-type Ca2+ current in human atrial myocytes. J Physiol 506(Pt 3):653\u2013663","journal-title":"J Physiol"},{"key":"2214_CR98","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/CIRCRESAHA.109.201251","volume":"105","author":"N Vignier","year":"2009","unstructured":"Vignier N, Schlossarek S, Fraysse B, Mearini G, Kramer E, Pointu H, Mougenot N, Guiard J, Reimer R, Hohenberg H, Schwartz K, Vernet M, Eschenhagen T, Carrier L (2009) Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice. Circ Res 105:239\u2013248","journal-title":"Circ Res"},{"key":"2214_CR99","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nm.3545","volume":"20","author":"G Wang","year":"2014","unstructured":"Wang G, McCain ML, Yang L, He A, Pasqualini FS, Agarwal A, Yuan H, Jiang D, Zhang D, Zangi L, Geva J, Roberts AE, Ma Q, Ding J, Chen J, Wang DZ, Li K, Wang J, Wanders RJ, Kulik W, Vaz FM, Laflamme MA, Murry CE, Chien KR, Kelley RI, Church GM, Parker KK, Pu WT (2014) Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med 20:616\u2013623","journal-title":"Nat Med"},{"key":"2214_CR100","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.yjmcc.2017.12.002","volume":"114","author":"L Wang","year":"2018","unstructured":"Wang L, Kim K, Parikh S, Cadar AG, Bersell KR, He H, Pinto JR, Kryshtal DO, Knollmann BC (2018) Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes. J Mol Cell Cardiol 114:320\u2013327","journal-title":"J Mol Cell Cardiol"},{"key":"2214_CR101","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/cvr\/cvt119","volume":"99","author":"ER Witjas-Paalberends","year":"2013","unstructured":"Witjas-Paalberends ER, Piroddi N, Stam K, van Dijk SJ, Oliviera VS, Ferrara C, Scellini B, Hazebroek M, ten Cate FJ, van Slegtenhorst M, dos Remedios C, Niessen HW, Tesi C, Stienen GJ, Heymans S, Michels M, Poggesi C, van der Velden J (2013) Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy. Cardiovasc Res 99:432\u2013441","journal-title":"Cardiovasc Res"},{"key":"2214_CR102","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/cvr\/cvu127","volume":"103","author":"ER Witjas-Paalberends","year":"2014","unstructured":"Witjas-Paalberends ER, Guclu A, Germans T, Knaapen P, Harms HJ, Vermeer AM, Christiaans I, Wilde AA, Dos Remedios C, Lammertsma AA, van Rossum AC, Stienen GJ, van Slegtenhorst M, Schinkel AF, Michels M, Ho CY, Poggesi C, van der Velden J (2014) Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations. Cardiovasc Res 103:248\u2013257","journal-title":"Cardiovasc Res"},{"key":"2214_CR103","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.stem.2015.04.020","volume":"17","author":"H Wu","year":"2015","unstructured":"Wu H, Lee J, Vincent LG, Wang Q, Gu M, Lan F, Churko JM, Sallam KI, Matsa E, Sharma A, Gold JD, Engler AJ, Xiang YK, Bers DM, Wu JC (2015) Epigenetic regulation of phosphodiesterases 2A and 3A underlies compromised beta-adrenergic signaling in an iPSC model of dilated cardiomyopathy. Cell Stem Cell 17:89\u2013100","journal-title":"Cell Stem Cell"},{"key":"2214_CR104","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/hmg\/ddv468","volume":"25","author":"SP Wyles","year":"2016","unstructured":"Wyles SP, Li X, Hrstka SC, Reyes S, Oommen S, Beraldi R, Edwards J, Terzic A, Olson TM, Nelson TJ (2016) Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells. Hum Mol Genet 25:254\u2013265","journal-title":"Hum Mol Genet"},{"key":"2214_CR105","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/CIRCRESAHA.114.300558","volume":"114","author":"X Yang","year":"2014","unstructured":"Yang X, Pabon L, Murry CE (2014) Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 114:511\u2013523","journal-title":"Circ Res"},{"key":"2214_CR106","doi-asserted-by":"publisher","unstructured":"Yeung C, Enriquez A, Suarez-Fuster L, Baranchuk A (2018) Atrial fibrillation in patients with inherited cardiomyopathies. Europace. https:\/\/doi.org\/10.1093\/europace\/euy064","DOI":"10.1093\/europace\/euy064"},{"key":"2214_CR107","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1161\/CIRCRESAHA.117.311080","volume":"120","author":"Y Yoshida","year":"2017","unstructured":"Yoshida Y, Yamanaka S (2017) Induced pluripotent stem cells 10 years later: for cardiac applications. Circ Res 120:1958\u20131968","journal-title":"Circ Res"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-018-2214-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-018-2214-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-018-2214-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:04:00Z","timestamp":1720677840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-018-2214-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2214"],"URL":"https:\/\/doi.org\/10.1007\/s00424-018-2214-0","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"30 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"T.E. is co-founder of EHT Technologies GmbH, a university spin-off providing equipment for EHT generation and analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}